Regional chemotherapy of non-resectable liver metastases from colorectal cancer - Literature and institutional review

Langenbeck's Archives of Surgery

Volumn 384, Issue 4, 1999, Pages 344-353

  Link, K H ^a   Kornmann, M ^a   Formentini, A ^a   Leder, G ^a   Sunelaitis, E ^a   Schatz, M ^a   Pressmar J ^a   Beger, H G ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Colorectal liver metastasis; Hepatic artery infusion; Regional chemotherapy; Review; Surgery

Indexed keywords

FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C; MITOXANTRONE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER METASTASIS; LIVER RESECTION; LIVER TOXICITY; MAJOR CLINICAL STUDY; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TREATMENT OUTCOME;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; NEOADJUVANT THERAPY;

EID: 0032878030     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004230050212     Document Type: Article

References (74)

1. Advanced Colorectal Cancer Meta-Analysis Project (1992) Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 10:896-903
2. Aigner KR (1988) Isolated liver perfusion: 5-year results. Reg Cancer Treat 1:11-20
3. Aigner KR, Link KH, Stemmler S, Warthona M (1985) Intraarterielle Infusion, experimentelle und pharmakokinetische Grundlagen - Klinik. Beitr Onkol 21:84-107
4. Aigner KR, Walther H, Link KH (1988) Isolated liver perfusion with MMC/5-FU - surgical technique, pharmacokinetics, clinical results. Contrib Oncol 29:229-246
5. Alexander HR, Bartlett DL, Libutti SK (1998) Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver. J Clin Oncol 16:1479-1489
6. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J (1994) Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases Lancet 344:1255-1260
7. Arai Y, Inaba Y (1997) Weekly high dose 5-FU HAI for unresectable liver metastases from colorectal cancer in patients without extra-hepatic lesions. Reg Cancer Treat Suppl 1:56
8. Arbuck SG (1989) Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer. Cancer 63:1036-1044
9. Archer SG, Gray BN (1989) Vascularization of small liver metastases. Br J Surg 76:545-548
10. Ballantyne GH, Quinn J (1993) Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 71:4252-4256
11. Becker HD, Borchard F, Büchler M, Dippold W, Eckhardt V, Eigler FW, Gabbert H, Grabenbauer G, Hermanek P, Hossfeld D, Junginger T, et al. (1998) Leitlinien der Deutschen Gesellschaft für Chirurgie und der Deutschen Krebsgesellschaft. Lebermetastasen. Mitteilungen der Deutschen Gesellschaft für Chirurgie 5[Suppl]:G81
12. Bierman HR, Miller ER, Byron RL, Dod KS, Kelly KH, Block DH (1951) Intra-arterial catheterization of viscera in man. AJR Am J Roentgenol 66:555-567
13. Buyse M (1996) Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 88:252-258
14. Cantore M, Fiorentini G, Poddie D, Bertani M, Davitti B, Riitano G, Cavazzini G, Amigoni A, Guglielminetti D, Vaglini M, et al. (1995) Hypoxic abdominal perfusion (HAP): rationale and evaluation of a new technique. Reg Cancer Treat 8:64-66
15. Casillas S, Dietz DW, Brand MI, Jones SC, Vladisavljevic A, Milsom JW (1997) Perfusion to colorectal cancer liver metastases is not uniform and depends on tumor location and feeding vessel. J Surg Res 67:179-185
16. Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM (1987) A prospective randomized trial of regional versus systemic continous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206:685-693
17. Civalleri D, Cafiero F, Cosimelli M, Craus W, Doci R, Repetto M, Simoni GA (1986) Regional arterial chemotherapy of liver tumours. I. Performance comparison between a totally implantable pump and a conventional access system. Eur J Surg Oncol 12:277-282
18. Civalleri D, DeCian F, Pellicci R, Balletto N, Simoni G, Cosimelli M, Mondini G, Bignami P, Cagol PP (1998) Differential device performances for hepatic arterial chemotherapy: a technical report on totally implantable pumps and ports for both continuous and bolus infusion. Eur Surg Res 30:26-33
19. Daly JM, Kemeny N, Sigurdson ER, Oderman P, Thom A (1987) Regional infusion for colorectal hepatic metastases. Arch Surg 122:1273-1277
20. Davidson BS, Izzo F, Chase JL, DuBrow RA, Patt Y, Hohn DC, Curley SA (1996) Alternating floxuridine and 5-fluorouracil hepatic arterial chemotherapy for colorectal liver metastases minimizes biliary toxicity. Am J Surg 172:244-247
21. Durand-Zaleski I, Roche B, Buyse M, Carlson R, O'Connell MJ, Rougier P, Chang AE, Sondak VK, Kemeny MM, Allen-Mersh TG, et al. (1997) Economic implications of hepatic arterial infusion chemotherapy in treatment of nonresectable colorectal liver metastases. Meta-analysis group in cancer. J Natl Cancer Inst 89:790-795
22. Durand-Zaleski I, Earlam S, Fordy C, Davies M, Allen-Mersh TG (1998) Cost-effectiveness of systematic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases. Cancer 83:882-888
23. Eder M, Weiss M (1991) Hämatogene Lebermetastasen - humanpathologische Grundlagen. Chirurg 62:705-709
24. Elias D, Lasser P, Rougier P, Ducreux M, Bognel C, Roche A (1995) Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg 180:213-219
25. Fiorentini G, Davitti B, Poddie D, Cantore M, Smerieri F, Fosser V, Dazzi C, Gugliemi A, Tumolo S, Guglielminetti D, et al. (1994) Hepatic arterial infusion (HAI) of high dose chemotherapy plus caval chemofiltration vs HAI of prolonged low doses in patients with liver metastases from colorectal carcinoma: result of a prospective randomized trial. Reg Cancer Treat 7:165-168
26. Fiorentini G, Pancera G, Tumolo S, Barni S, Ceravolo C, Cortesi E, Cornella P, Massidda B, Cirillo F, Montinari F, et al. (1999) Locoregional FUDR (LF) alone or in combination with systemic FU-FA (SY) in liver metastases from colorectal cancer (CRC): preliminary results of a randomized Italian trial (abstract O51). Proceedings of the 9th International Congress of Anti-Cancer Treatment, Paris, p 144
27. Fujimoto S, Miyazaki M, Kitsukawa Y, Higuchi M, Okui K (1985) Long-term survivors of colorectal cancer with unresectable hepatic metastases. Dis Colon Rectum 28:588-591
28. Fujita S, Miyake H, Akasu T, Moriya Y (1998) Hepatic arterial infusion (HAI) of 5-FU for unresectable liver metastases from colorectal cancer. J Jpn Soc Coloproctol 51:974
29. Grage TB, Vassilopoulos PP, Shingleton WW, Jubert AV, Elias EG, Aust JB, Moss SE (1979) Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: a central oncology group study. Surgery 86:550-555
30. Hodgson WB (1986) Treatment of colorectal hepatic metastases by intrahepatic chemotherapy alone or as an adjuvant to complete or partial removal of metastatic disease. Ann Surg 203:429-425
31. Hohn DC, Shea WJ, Gemlo BT, Lewis BJ, Stagg RJ, Ignoffo RJ, Rayner AA (1988) Complications and toxicities of hepatic arterial chemotherapy. Contr Oncol 29:169-180
32. Hohn DC, Stagg RJ, Friedman MA, Hannigan JF, Rayner AA, Ignoffo RJ, Acord P, Lewis BJ (1989) A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group Trial. J Clin Oncol 7:1646-1654
33. Hughes KS, Simon R, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG, Maclean BJ, et al. (1986) Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 100:278-284
34. Hughes KS, Simon R, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG, et al. (1988) Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery 103:278-288
35. Kemeny N (1995) Chemotherapy for colorectal carcinoma: one small step forward, one step backward. J Clin Oncol 13:287-290
36. Kemeny N, Daly JM, Reichman B, Geller N, Botet J, Oderman P (1987) Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal cancer. Ann Intern Med 107:459-465
37. Kemeny N, Seiter K, Niedzwiecki D, Chapman D, Sigurdson E, et al. (1992) A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 69:327-334
38. Kemeny N, Conti JA, Cohen A, Campana P, Huang Y, Shi WJ, Botet J, Bertino JR (1994) Phase II study of hepatic arterial floxuridine, leucovorin and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 12:2288-2295
39. Kemeny N, Buyse M, Rougier P, Carlson R, Allen-Mersh TG, O'Connell M, Chang A, Sondak V, Kemeny M, Levy E, et al. (1996) A meta-analysis of hepatic arterial infusion in patients with liver metastases from colorectal cancer. Proc Am Soc Clin Oncol 15:202
40. Khazei AM, Watkins E, Sullivan RD (1964) Hepatic artery catheterization for prolonged infusion chemotherapy of liver cancer. Surg Clin North Am 44:763-778
41. Kornmann M, Link KH, Lenz HJ, Pillasch J, Metzger R, Butzer U, Leder GH, Weindel M, Safi F, Danenberg KD, et al. (1997) Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy. Cancer Lett 118:29-35
42. Köhne-Wömpner C, Schmoll H, Harstick A, Rustum Y (1992) Chemotherapeutic strategies in metastatic colorectal cancer: an overview of current clinical trials. Semin Oncol 19:105-125
43. Link KH (1993) Chemosensitivitätsuntersuchungen zur Optimierung der regionalen Chemotherapie solider Tumoren. Grundlagen und klinische Applikation. [Habilitationsschrift]. University of Ulm, Germany
44. Link KH, Aigner KR, Kuehn W, Schwemmle K, Kern DH (1986) Prospective correlative chemosensitivity testing in high-dose intraarterial chemotherapy for liver metastases. Cancer Res 46:4837-4848
45. Link KH, Aigner KR, Peschau K, Warthona M, Schwemmle K, Danenberg PV (1988) Concentration and time dependence of the toxicity of fluorinated pyrimidines to HT 29 colorectal carcinoma cells. Cancer Chemother Pharmacol 22:58-62
46. Link KH, Staib L, Beger HG (1989) Influence of exposure concentration and exposure time c×t on toxicity of cytostatic drugs to HT29 human colorectal carcinoma cells. Reg Cancer Treat 2:189-197
47. Link KH, Kreuser ED, Safi F, Ullrich J, Schalhorn A, Schmoll E, Beger HG (1993) Die intraarterielle Chemotherapie mit 5-FU und Folinsäure (FA, Rescuvolin) im Therapiekonzept bei nicht resektablen kolorektalen Lebermetastasen. Tumordiagn u Ther 14:224-231
48. Link KH, Kornmann M, Leder GH, Butzer U, Pillasch J, Staib L, Gansauge F, Beger HG (1996) Regional chemotherapy directed by individual chemosensitivity testing in vitro: a prospective decision aiding trial. Clin Cancer Res 2:1469-1474
49. Link KH, Staib L, Kreuser ED, Beger HG (1996) Adjuvant treatment of colon and rectal cancer: impact of chemotherapy, radiotherapy, and immunotherapy on routine postsurgical patient management. Recent Results Cancer Res 142:311-352
50. Link KH, Leder GH, Pillasch J, Butzer U, Staib L, Kornmann M, Brückner U, Beger HG (1998) In vitro concentration response studies and in vitro phase II tests as the experimental basis for regional chemotherapeutic protocols. Semin Surg Oncol 14:189-201
51. Link KH, Kornmann M, Leder G, Formentini A, Pillasch J, Sunelaitis E, Schatz M, Pressmar J, Beger HG (1999a) Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU+folinic acid and mitomycin C. Jpn J Cancer Chemother 26:269-281
52. Link KH, Pillasch J, Formentini A, Sunelaitis E, Leder G, Safi F, Kornmann M, Beger HG (1999b) Downstaging by regional chemotherapy of primarily non-resectable isolated colorectal liver metastases. Eur J Surg Oncol (in press)
53. Lorenz M (1997) A pilot study on weekly 24-hour-hepatic arterial infusion (HAI) for unresectable isolated colorectal metastases. Proceedings of 8th International Conference of Regional Cancer Treatment. Reg Cancer Treat Suppl, pp 56
54. Lorenz M, Müller HH, Staib-Sebler E, Gassel HJ, Ulrich C, et al. (1997) Standard/studies for regional treatment of colorectal metastases (ALM-study). Proceedings of 8th International Conference of Regional Cancer Treatment. Reg Cancer Treat Suppl, pp 72
55. Lorenz M, Staib-Sebler E, Gog C, Vetter D, Petrowsky H, Müller HH (1999) Die Stellung der regionalen Langzeitchemotherapie bei Lebermetastasen. Chirurg 70:141-153
56. Martin KJ, O'Connell MJ, Wieand HS, Fitzgibbons RJ, Mailliard JA, Rubin J, et al. (1990) Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. Arch Surg 125:1022-1027
57. Maruo H, Kosaka A (1994) Evaluation of cases of metastatic liver tumors resected following intra-arterial infusion chemotherapy. Jpn J Cancer Chemother 21:2143-2146
58. Niinobu T, Shibata T, Takada K, Kitada M, Tsukahara Y, Iihara K, Ikeda K, Ogawa M, Hayashi N, Takami M, et al. (1997) Complication of reservoir hepatic artery infusion chemotherapy and additional treatments. Jpn J Cancer Chemother 24:1843-1847
59. O'Connell MJ, Nagorney DM, Bernath AM, Schroeder G, Fitzgibbons RJ, Mailliard JA, Burch P, Bolton JS, Colon-Otero G, Krook JE (1998) Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver. J Clin Oncol 16:2528-2533
60. Patt YZ, Mavligit GM (1991) Arterial chemotherapy in the management of colorectal cancer. An overview. Semin Oncol 18:478-490
61. Patt YZ, McBride CM, Ames FC, Claghorn L, Cleary KR, Boddie AW, Charnsangavej C, Mavligit GM (1987) Adjuvant perioperative hepatic arterial mitomycin C and floxuridine combined with surgical resection of metastatic colorectal cancer in the liver. Cancer 59:867-873
62. Rougier P, Lasser PH, Elias D, Ghosn M, Ducreux M, Lumbroso J, Sidibe S, Droz JP (1989) Intra-arterial hepatic chemotherapy for metastatic liver from colo-rectal carcinoma origin. Selective Cancer Ther 5:47-54
63. Rougier P, Laplanche A, Huguier M, Hay JM, Ollivier JM, Escat J, et al. (1992) Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 10:1112-1118
64. Safi F, Bittner R, Roscher R, Schumacher KA, Gaus W, Beger HG (1989) Regional chemotherapy for hepatic metastases of colorectal carcinoma. Cancer 64:379-387
65. Schwemmle K, Link KH, Rieck B (1987) Rationale and indications for perfusion in liver tumors: current data. World J Surg 11:534-540
66. Sigurdson ER, Ridge JA, Kemeny N, Daly JM (1987) Tumor and liver drug uptake following hepatic artery and portal vein infusion. J Clin Oncol 5:1836-1840
67. Staib-Sebler E, Lorenz M, Gog C, Encke A (1995) Continuous arterial 5-fluorouracil and folinic acid chemotherapy for colorectal liver metastases. Onkologie 18:240
68. Taguchi T (1991) Intraarterial chemotherapy combined with mitomycin C and degradable starch mircrospheres for unresectable metastatic liver cancer. In: Taguchi T, Aigner KR (eds) Mitomycin C in cancer chemotherapy today. Excerpta Medica, Tokyo, pp 149-151
69. Taguchi T, Ogawa N, Bunke B, Nilsson B (1992) The use of degradable starch microspheres (Spherex) with intra-arterial chemotherapy for the treatment of primary and secondary liver tumours -results of a phase III clinical trial. Reg Cancer Treat 4:161-165
70. Taylor I (1997) An international multi-disciplinary approach to the management of advanced colorectal cancer. Eur J Surg Oncol 23[suppl A]:45
71. Venook AP (1999) Nonsurgical management of hepatic metastases. In: Perry MC (ed) American society of clinical oncology educational book. Alexandria, VA pp 333-337
72. Warren HW, Anderson JH, Gorman PO, Kane E, Kerr DJ, Cooke TG, McArdle CS (1994) A phase II study of regional 5-fluorouracil infusion with intravenous folinic acid for colorectal liver metastases. Br J Cancer 70:677-680
73. Weiss L (1989) Metastatic inefficiency and regional therapy for liver metastases from colorectal carcinoma. Reg Cancer Treat 2:77-81
74. Yasuno M, Mori T, Takahashi K (1999) Results of the hepatic resection of liver metastasis from colorectal carcinoma after continuous hepatic arterial infusion of chemotherapy: new strategy for far advanced colorectal liver metastasis. Proceedings of the 9th International Congress of Anti-Cancer Treatment p 55